| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Laboratory of Immunology and
Laboratory of Molecular and Developmental Biology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892; and
Howard Hughes Medical Institute-National Institutes of Health, Research Scholars Program, Bethesda, MD 20814
The role of Th17 lymphocytes in immunopathogenic processes has been well established, but little is known about their basic cell features. In this study, we compared polarized Th1 and Th17 for key biological activities related to pathogenicity and trafficking. Th1 and Th17 lineages were derived from TCR-transgenic CD4 murine cells specific against hen egg lysozyme. When adoptively transferred into mice expressing hen egg lysozyme in their eyes, both Th1 and Th17 induced ocular inflammation but with slight differences in histological pathology. PCR analysis revealed selective expression of IFN-
or IL-17 in eyes of Th1 or Th17 recipients, respectively. Additionally, Th1 and Th17 were found to differ in three other key activities: 1) Th17 cells were inferior to Th1 cells in their capacity to trigger massive lymphoid expansion and splenomegaly; 2) the proportion of Th1 cells among infiltrating cells in inflamed recipient eyes declined rapidly, becoming a minority by day 7, whereas Th17 cells remained in the majority throughout this period; and 3) remarkable differences were noted between Th1 and Th17 cells in their expression of certain surface markers. In particular, reactivated Th1 expressed higher levels of CD49d and 
4β7 (mucosal homing) in vitro and higher levels of CXCR3 (Th1 trafficking) in vivo. Reactivated Th17, however, expressed higher levels of Eβ7 (epithelial tissue homing) and CD38 (activation, maturation and trafficking) in vitro, but in vivo Th17 expressed higher levels of 4β7 and CCR6 (lymphocyte trafficking). These data reveal that Th1 and Th17 cells differ in several key biological activities influencing migration and pathogenic behavior during inflammatory disease.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by the Intramural Research Program of the National Eye Institute, National Institutes of Health.
2 C.A.C. and G.S. contributed equally to this work.
3 Address correspondence and reprint requests to Dr. Igal Gery, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Building 10, Room 10N208, Bethesda, MD 20892. E-mail address: geryi{at}nei.nih.gov
4 Abbreviations used in this paper: Tg, transgenic; HEL, hen egg lysozyme; MNL, mononuclear leukocyte; WT, wild type.
This article has been cited by other articles:
|
|
 |
|
  G. Shi, M. Ramaswamy, B. P. Vistica, C. A. Cox, C. Tan, E. F. Wawrousek, R. M. Siegel, and I. Gery Unlike Th1, Th17 Cells Mediate Sustained Autoimmune Inflammation and Are Highly Resistant to Restimulation-Induced Cell Death J. Immunol., December 1, 2009; 183(11): 7547 - 7556. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Horie, N. Abiru, Y. Nagayama, G. Kuriya, O. Saitoh, T. Ichikawa, Y. Iwakura, and K. Eguchi T Helper Type 17 Immune Response Plays an Indispensable Role for Development of Iodine-Induced Autoimmune Thyroiditis in Nonobese Diabetic-H2h4 Mice Endocrinology, November 1, 2009; 150(11): 5135 - 5142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Brand Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease Gut, August 1, 2009; 58(8): 1152 - 1167. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Li, J. M. Reynolds, R. D. Stout, D. A. Bernlohr, and J. Suttles Regulation of Th17 Differentiation by Epidermal Fatty Acid-Binding Protein J. Immunol., June 15, 2009; 182(12): 7625 - 7633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yamada, J. Hamuro, A. Fukushima, T. Ohteki, K. Terai, Y. Iwakura, H. Yagita, and S. Kinoshita MHC-Matched Corneal Allograft Rejection in an IFN-{gamma}/IL-17-Independent Manner in C57BL/6 Mice Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2139 - 2146. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Phan and M. L. Disis Tumor-Specific Th1 Lymphocytes: Modulation of the Tumor Microenvironment to Enhance Cross-Priming Am. Assoc. Cancer Res. Educ. Book, April 18, 2009; 2009(1): 199 - 202. [Full Text] [PDF]
|
|
|
|
|
|
G. Shi, C. A. Cox, B. P. Vistica, C. Tan, E. F. Wawrousek, and I. Gery Phenotype Switching by Inflammation-Inducing Polarized Th17 Cells, but Not by Th1 Cells J. Immunol., November 15, 2008; 181(10): 7205 - 7213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Steinman A rush to judgment on Th17 J. Exp. Med., July 7, 2008; 205(7): 1517 - 1522. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
